Veeva Systems Inc. (VEEV)
COVID-19 UPDATE: EClinical Solutions Market Explosive Growth || Parexel International Corporation, Oracle, Medidata Solutions, Inc., Veeva Systems
A DBMR team makes use of simple language and easy to understand statistical images to provide thorough information and in-depth data on the industry and Global eClinical Solutions Market. The company profiles of all the key players and brands that
Veeva Systems gains after Roche selects Development Cloud products (NYSE:VEEV)
Ahead of the R&D & Quality Summit kickoff tomorrow, Veeva Systems (NYSE:VEEV) announces that Roche (OTCQX:RHHBY) has selected Veeva Development Cloud appli
EClinical Solutions Market Outlook, Geographical Segmentation, Industry Size & Share, Comprehensive Analysis to 2026 | Parexel International Corporation, Oracle, Medidata Solutions, Inc., Veeva Systems, ERT Clinical, eClinical Solutions LLC
EClinical Solutions Market research report has been prepared with a nice combination of industry insight, smart solutions, practical solutions and newest technology to give better user experience. Under market segmentation chapter, research and analysis is done based on several market
eClinical Solutions Market 2020 Dynamics, Positioning, Segmentations, Competitive Landscaping And Benchmarking, Leading Players are Oracle, Medidata Solutions, Veeva Systems, IBM Corporation, Anju Software, ICON
When globalization is growing day by day, many businesses call for global market research consisting of actionable market insights that helps with decision making. This eClinical Solutions Market analysis report gives out the data for industry about company profile, product
Global eClinical Solutions Market 2020-2026 Refreshing Trends || Major Giants – Oracle, Medidata Solutions, Inc., Veeva Systems, ERT Clinical, eClinical Solutions LLC, IBM Corporation
DBMR has added a new report titled Global eClinical Solutions Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The data and the information regarding the industry are taken from
Veeva partners with RedHill Bio to advance Opaganib in COVID-19 (NASDAQ:RDHL)
Veeva Systems (NYSE:VEEV) and Bioforum collaborates with RedHill Biopharma (NASDAQ:RDHL) on a global Phase 2/3 clinical study evaluating opaganib (Yeliva,
Worldwide Risk-based Monitoring Software Industry to 2026 - Featuring MasterControl, Veeva Systems & Techso Among Others -
DUBLIN--(BUSINESS WIRE)--The "Global Risk-based Monitoring Software Market Analysis 2020" report has been added to's offering. The Global Risk-based Monitoring Software market is expected to reach $652.40 million by 2026 growing at a CAGR of 15.3% from 2019 to 2026. Risk-based monitoring (RBM) software is a clinical trial-monitoring method that fulfills regulatory necessities. It employs various tools, platforms and dashboards to identify signals, which indicate potential
A senior portfolio manager at Morgan Stanley's $665 billion investment management business tells us why the tech stock plunge isn't a cue to abandon the sector — and where to find the biggest gains as the recovery resumes
Summary List Placement The stock market refuses to take its time this year. First there was a historic sell-off, then came the stunning rally, and now it's been followed by an ultra-fast drop led by falling tech stocks . In just three days of trading between September 3 and September 8, the Nasdaq Composite slumped 10%, its fastest correction ever. Downturns in stocks are normal, although the speed of this one was unusual, and nothing about recent circumstances has been normal anyway. Andrew Slimmon, a senior portfolio manager at Morgan Stanley Investment Management who advises on the firm's long-equity strategies, says there's good news for investors who've been shaken up by the events of early September: The slump isn't a sign of impending disaster. "The tech stocks and growth stocks are oversold," Slimmon told Business Insider in an exclusive interview. "I don't see the big mega-cap tech stocks as outrageously expensive. So I think you want to hold position in those stocks now." But even though he doesn't see signs of a ruinous tech bubble, he says many cloud computing and work from home companies have already priced in a huge amount of good news.
Veeva Systems EPS beats by $0.08, beats on revenue (NYSE:VEEV)
Veeva Systems (NYSE:VEEV): Q2 Non-GAAP EPS of $0.72 beats by $0.08; GAAP EPS of $0.58 beats by $0.06. Revenue of $353.68M (+32.5% Y/Y) beats by $13.68M. Sh
S&P 500 on Trend, Nvidia Ahead of Earnings, Tesla Targets, Trading Veeva Systems
S&P 500 on Trend, Huawei, Nvidia Ahead of Earnings, Trading Veeva Systems: Market Recon…AAP
Veeva Systems (VEEV) earnings: is there more upside for the stock?
Veeva Systems Inc. (VEEV) shares are trading at $91.61, up 3%. The company is announcing its quarterly earnings results on Wednesday after the market close. What's driving Veeva stock price? What's VEEV stock price forecast?
Veeva Stock Is Down Today - But Should You Care?
Veeva shares dropped today after the CRM leader for the pharma industry beat estimates for the third quarter. Should you be worried about this?
Follow Us